Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US6277877A · kind A · utility
16Cited by
13References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2000 |
| Grant date | Aug 21, 2001 |
| Priority date | — |
| Expiry date | Aug 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formula (I) ##STR1## wherein PA1 R.sub.6 is carboxy, (C.sub.1 -C.sub.8)alkoxycarbonyl, benzyloxycarbonyl, C(O)NR.sub.8 R.sub.9 or C(O)R.sub.12 as glycogen phosphorylase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperisulinemia, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.